Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

When Cathie Wood’s ARK Invest adds stocks to its portfolio, it tends to catch attention. Wood is not your typical Wall Street investor; her strategy is based on strong conviction, disruptive ...

Gene-editing stocks are a promising investment because the field is steadily advancing in the areas of medicine and biotechnology. Examples include CRISPR and other gene-editing technologies. These ...

Eli Lilly’s LLY recent announcement to acquire Verve Therapeutics, Inc VERV, a Boston-based clinical-stage company developing genetic medicines for cardiovascular disease, has put the spotlight on ...

CRISPR Therapeutics CRSP and Beam Therapeutics BEAM are leading developers of therapies that utilize the Nobel Prize-winning CRISPR/Cas9 gene editing technology. While CRSP is the first and only ...

While Vertex Pharmaceuticals took Casgevy to market, CRISPR Therapeutics AG (NASDAQ: CRSP) was a key collaborator in the development of the treatment, which had a 93.5% effective rate for treating SCD ...

Genetics is the study of genes, their variations and hereditary characteristics, as well as how these traits are passed on ...

Three stocks that look incredibly cheap right now which you may want to consider buying are Vertex Pharmaceuticals (NASDAQ: ...

This little company's scientific breakthrough opened up a whole new sliver of the drug market (although it's still leading the developmental race).

Top 5 biotech stocks jumping into the top 10% momentum this week—ADCT, ARQT, CLLS, ENTO, HOTH—amid rapid sector rallies.

Oral presentation highlights significant reduction in HBV DNA integration and other clinically-relevant biomarkers from the EBT-107 therapeutic ...

The accepted abstract titles are available online on the AHA website. The data in the abstracts and presentations are ...